Phase I, Randomized, Rater and Participant Blinded Placebo-Controlled Study of the Safety, Reactogenicity, Tolerability and Immunogenicity of H1N1 Influenza Vaccine Delivered by VX-103 (a MIMIX Microneedle Patch [MAP] System) in Healthy Adults